Your session is about to expire
← Back to Search
Speech Sequencing Therapies for Stuttering
Study Summary
This trial is testing hypotheses about the brain processes involved in speech production in order to improve understanding of stuttering and develop new therapies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My hearing is good at specific test frequencies.I am healthy with no history of brain, speech, or hearing problems, except for stuttering.I am not on medications that could affect my speech or language.You cannot participate in MRI studies if you have had seizures, severe claustrophobia, metal implants in your body, or if you are pregnant.You cannot participate if you have metal implants in your head, certain medical devices in your body, a history of seizures, significant scalp injuries, or if you are pregnant.My child is between 6 and 8 years old and does not have a neurological disorder except for stuttering.My child has passed a hearing test at the required levels.My child will undergo tests to check their speech, hearing, and thinking skills.You need to have normal vision or wear glasses or contacts to correct your vision.I performed within the normal range for my age in a specific memory test.I am healthy with no history of brain, speech, or hearing problems.People with PPA must have mild cognitive impairment or mild dementia.I can safely undergo tDCS or MRI procedures.People who have trouble speaking fluently will be checked by a speech expert to see how severe their stuttering is and to make sure there are no other speech or language problems.
- Group 1: Sub-syllabic learning and sham tDCS
- Group 2: Sub-syllabic learning and anodal tDCS of inferior frontal sulcus
- Group 3: Multisyllabic learning in children
- Group 4: Multisyllabic learning and fMRI in adults
- Group 5: Sub-syllabic learning and fMRI
- Group 6: Sub-syllabic learning in PPA
- Group 7: Sub-syllabic learning and anodal tDCS of cerebellum
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What goal is this clinical experiment attempting to achieve?
"This medical study will observe and measure changes in reaction time as the primary outcome. Subsidiary objectives include assessing cortical white matter connectivity, stuttering severity (using The Stuttering Severity Instrument), and forward digit span scores from a Uniform Data Set neuropsychological test battery for correlations between phonological working memory and task performance. Evaluations of these metrics shall occur both at baseline and immediately following intervention."
Is this clinical investigation recruiting participants right now?
"Alas, according to the information on clinicaltrials.gov this investigation is not currently enrolling patients - it was initially listed on July 1st 2022 and has since been updated June 27th 2022. Though this trial has ceased its recruitment process, 128 other studies are actively searching for participants at present."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger